Ligand Pharmaceuticals Inc (LGND)
73.90
+1.58
(+2.18%)
USD |
NASDAQ |
May 03, 16:00
73.90
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Free Cash Flow: -4.272M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.272M |
| September 30, 2023 | 90.71M |
| June 30, 2023 | 98.75M |
| March 31, 2023 | 104.32M |
| December 31, 2022 | 119.93M |
| September 30, 2022 | 93.07M |
| June 30, 2022 | 96.13M |
| March 31, 2022 | 109.82M |
| December 31, 2021 | 70.04M |
| September 30, 2021 | 43.50M |
| June 30, 2021 | 35.95M |
| March 31, 2021 | 40.56M |
| December 31, 2020 | 50.13M |
| September 30, 2020 | 43.88M |
| June 30, 2020 | 26.98M |
| March 31, 2020 | -57.67M |
| December 31, 2019 | -29.34M |
| September 30, 2019 | 10.58M |
| June 30, 2019 | 43.85M |
| March 31, 2019 | 178.56M |
| December 31, 2018 | 194.06M |
| September 30, 2018 | 192.80M |
| June 30, 2018 | 193.36M |
| March 31, 2018 | 130.11M |
| December 31, 2017 | 88.57M |
| Date | Value |
|---|---|
| September 30, 2017 | 82.97M |
| June 30, 2017 | 71.66M |
| March 31, 2017 | 52.98M |
| December 31, 2016 | 41.19M |
| September 30, 2016 | 27.28M |
| June 30, 2016 | 20.10M |
| March 31, 2016 | 33.97M |
| December 31, 2015 | 30.86M |
| September 30, 2015 | 26.75M |
| June 30, 2015 | 21.06M |
| March 31, 2015 | 19.44M |
| December 31, 2014 | 16.07M |
| September 30, 2014 | 19.42M |
| June 30, 2014 | 15.38M |
| March 31, 2014 | 14.66M |
| December 31, 2013 | 15.75M |
| September 30, 2013 | 6.932M |
| June 30, 2013 | 2.714M |
| March 31, 2013 | -1.505M |
| December 31, 2012 | -8.483M |
| September 30, 2012 | -6.513M |
| June 30, 2012 | -2.897M |
| March 31, 2012 | -9.968M |
| December 31, 2011 | -4.125M |
| September 30, 2011 | -9.477M |
Free Cash Flow Range, Past 5 Years
-57.67M
Minimum
Mar 2020
119.93M
Maximum
Dec 2022
51.94M
Average
43.88M
Median
Sep 2020
Free Cash Flow Benchmarks
| ANI Pharmaceuticals Inc | 100.45M |
| ADMA Biologics Inc | 3.819M |
| Viking Therapeutics Inc | -54.87M |
| Voyager Therapeutics Inc | 74.66M |
| Palatin Technologies Inc | -26.75M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 8.065M |
| Cash from Investing (Quarterly) | -10.28M |
| Cash from Financing (Quarterly) | 5.315M |
| Free Cash Flow Per Share (Quarterly) | -2.415 |
| Free Cash Flow to Equity (Quarterly) | -42.68M |
| Free Cash Flow to Firm (Quarterly) | -42.68M |
| Free Cash Flow Yield | -0.33% |